What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Endocrinology
The scientist’s investigation covers issues in Endocrinology, Internal medicine, Receptor, Neuroscience and Neuropeptide Y receptor.
His work on Endocrinology deals in particular with Hippocampus, Central nervous system, Hippocampal formation, Cholinergic and Nucleus accumbens.
His Receptor research is multidisciplinary, incorporating perspectives in Olfactory bulb and Binding site.
His Neuroscience study combines topics in areas such as Neuropeptide and Pathogenesis.
His Neuropeptide Y receptor study incorporates themes from Elevated plus maze and Inhibitory postsynaptic potential.
Within one scientific family, he focuses on topics pertaining to Nitric oxide under Biochemistry, and may sometimes address concerns connected to Pharmacology.
His most cited work include:
- XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors (807 citations)
- A proposal for the classification of sigma binding sites. (675 citations)
- International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. (658 citations)
What are the main themes of his work throughout his whole career to date?
Rémi Quirion mainly focuses on Internal medicine, Endocrinology, Receptor, Neuroscience and Neuropeptide Y receptor.
His work in Acetylcholine, Neuropeptide, Muscarinic acetylcholine receptor, Agonist and Cholinergic is related to Internal medicine.
His studies in Endocrinology integrate themes in fields like Calcitonin gene-related peptide and Binding site.
His Binding site research is multidisciplinary, incorporating elements of Biophysics and Pharmacology.
To a larger extent, Rémi Quirion studies Biochemistry with the aim of understanding Receptor.
His biological study spans a wide range of topics, including Hypothalamus and Antagonist.
He most often published in these fields:
- Internal medicine (56.81%)
- Endocrinology (56.46%)
- Receptor (32.04%)
What were the highlights of his more recent work (between 2003-2020)?
- Endocrinology (56.46%)
- Internal medicine (56.81%)
- Neuroscience (23.89%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Endocrinology, Internal medicine, Neuroscience, Neuropeptide Y receptor and Receptor.
His research in Endocrinology intersects with topics in Neuropeptide and Calcitonin gene-related peptide.
In most of his Internal medicine studies, his work intersects topics such as Pharmacology.
He has researched Neuroscience in several fields, including Synaptic plasticity, Glutamatergic and Genetically modified mouse.
His work carried out in the field of Neuropeptide Y receptor brings together such families of science as Behavioural despair test, Area postrema and Open field.
Receptor is closely attributed to Binding site in his work.
Between 2003 and 2020, his most popular works were:
- Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis (302 citations)
- Psychosis pathways converge via D2high dopamine receptors. (280 citations)
- Neuroprotective effects of resveratrol against β‐amyloid‐induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C (245 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Neurotransmitter
Rémi Quirion focuses on Internal medicine, Endocrinology, Neuroscience, Pharmacology and Neuroprotection.
His Internal medicine and Neuropeptide, Dopamine, Hippocampal formation, Receptor and Dopamine receptor investigations all form part of his Internal medicine research activities.
His Receptor study combines topics from a wide range of disciplines, such as Behavioural despair test and Antidepressant.
His Endocrinology study combines topics in areas such as Calcitonin gene-related peptide, Neuropeptide Y receptor and Cell biology.
His study in Neuroscience is interdisciplinary in nature, drawing from both Signal transduction and Neurodegeneration.
The Pharmacology study combines topics in areas such as Sciatic nerve, Nerve injury and Receptor antagonist.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
